Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Victorhy in Severe Hand Hyperhidrosis
2023-507114-27-00Phase 2Completed
- Sponsor
- Dryox Health
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of TTB gel in Primary hyperhidrosis (PH) (3 arms), sponsored by Dryox Health. Primary endpoints: Mean absolute change from Day 1 in gravimetrically measured sweat production at Day 29 and Mean change in HDSS at Day 29 from Day 1. Started Jan 2024; status: completed.
02
Drugs
TTB gel
03
Conditions
Primary hyperhidrosis (PH)
Beyond the preview
Go deeper on 2023-507114-27-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-507114-27-00.